ArticleTranslational lung cancer research2025
Diagnostic utility of cryobiopsy for invasive mucinous lung adenocarcinoma.
Article in Translational lung cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Non-destructive three-dimensional structural assessment of transbronchial cryobiopsy specimens using phase-contrast X-ray CT: a proof-of-concept study.Translational lung cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Invasive mucinous lung adenocarcinoma (IMA) is challenging to diagnose via bronchoscopy due to its distinct histopathological characteristics, including poorly atypical tumor cells with abundant mucins. Given that cryobiopsy facilitates high-quality and quantity tissue sampling, we hypothesized that it could improve diagnostic success. This retrospective study aimed to determine whether cryobiopsy is a valid diagnostic tool for IMA. Methods: We retrospectively reviewed consecutive patients who underwent surgical resection for lung cancer at our institution between March 2017 and July 2024. Among them, patients diagnosed with IMA were selected. Those who had undergone a diagnostic biopsy for peripheral pulmonary lesions (PPLs) were included in the study. These patients were divided into two groups: cryo and conventional, based on whether cryobiopsy was performed. The diagnostic yield and safety profiles of both groups were compared. Results: Of 5,053 surgeries for lung cancer, 201 (4.0%) were diagnosed with IMA. Among them, 106 patients who had undergone bronchoscopy for PPLs were included in the analyses: 46 in the cryo group and 60 in the conventional group. The diagnostic yield was significantly higher in the cryo group than in the conventional group (93.5% Conclusions: Cryobiopsy is a valid technique for making a diagnosis of IMA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.